Where does Cellink Bioprinting AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cellink Bioprinting AB ranks #34,700 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cellink Bioprinting AB hold?

Cellink Bioprinting AB holds 7 US utility patents granted between 2022 and 2025, spanning 13 technology areas.

What is Cellink Bioprinting AB's Innovation Score?

Cellink Bioprinting AB has an Innovation Score of 49.3 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Cellink Bioprinting AB's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Cellink Bioprinting AB.

What does claim depth mean for Cellink Bioprinting AB's patents?

Cellink Bioprinting AB's patents average 15.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cellink Bioprinting AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cellink Bioprinting AB

Q: What technology areas does Cellink Bioprinting AB focus on?

Cellink Bioprinting AB's top technology area is B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering) with 7 patents, ranking #237 of 1,250 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 13 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cellink ranks #34,700 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 13 technology areas.

#34,700
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.3/100): 15.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34700 · Foreign Corporation #34,700 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #34,700/49,997
PHOTO-FINISH Cell and Molecular…
CPC-FOCUS B33Y · 13 areas
INNOV-PAR 49.3/100
CLAIMS-RICH 15.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Cell and Molecular Tissue Engineering, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cellink’s 49.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (15%) Velocity 20.0 pts (41%) Breadth 12.7 pts (26%) Claim depth 9.3 pts (19%)

Qualcomm Incorporated · highest

85
Cellink Bioprinting AB · this assignee

49
3D Lighting… · lowest

7

What this shows Cellink's Innovation Score is 49.3/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cellink?

Each dot is one of Cellink’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cellink’s own 15.6 claims/patent is ABOVE the 12.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cellink vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cellink's grants concentrate

Cellink Bioprinting AB is a focused PatentsView assignee: 13 CPC subclasses with 100% of grants classified under B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2022. By volume, Cellink sits between Cell and Molecular Tissue Engineering, LLC and Centipede Systems, Inc..

Cellink's three-year grant acceleration

Cellink Bioprinting AB shows 6 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cell and Molecula…

7
Cellavision AB

7
Cellaed Life Save…

7
Cellink AB

7
Cellotape

7
Cellply S R L

7
Centaur Analytics

7
Centipede Systems

7
Cellink Bioprinti… ◀

7

What this shows Cellink holds 7 patents at rank #34,805, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cellink

By rank, the assignees closest to #34,805 in granted patent volume.

Leaders in B33Y (Additive Manufacturing)

Other assignees with the most granted patents in Cellink's primary technology class.

Cellink's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Cellink Bioprinting AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	1	14.3%
2023	3	42.9%
2024	2	28.6%
2025partial year	1	14.3%

Which technologies does Cellink Bioprinting AB patent most?

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 7

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 7

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

G06N - Computing Arrangements Based ON Specific Computational Models 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

F24F - AIR-CONDITIONING; AIR-HUMIDIFICATION; VENTILATION; USE OF AIR Currents FOR Screening 1

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 1

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 1

G01K - Measuring TEMPERATURE; Measuring Quantity OF HEAT; Thermally-sensitive Elements NOT Otherwise Provided FOR 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cellink Bioprinting AB's patent record in context - here's where to go next.

Cellink Bioprinting AB's lead technology class is B33Y (Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective ), 100% of its portfolio - see every assignee active in that class. Explore B33Y
Ranked #34,700 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cellink Bioprinting AB against Cell and Molecular Tissue Engineering, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.